Sartorius Stedim Biotech News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

16.04.25	Sartorius Stedim Biotech publishes unaudited first quarter results for 2025 (EQS Group)
25.03.25	Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. (EQS Group)
17.02.25	Sartorius Stedim Biotech releases Universal Registration Document 2024 (EQS Group)
07.02.25	Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting (EQS Group)
28.01.25	Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024 (EQS Group)
17.10.24	Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024 (EQS Group)
18.07.24	Half-year results 2024 of SartoriusStedimBiotech (EQS Group)
18.07.24	Sartorius Stedim Biotech SA: Sartorius Stedim Biotech adjusts its guidance for fiscal year 2024 and presents results for H1 2024 (EQS Group)
17.05.24	Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast (EQS Group)
18.04.24	Sartorius Stedim Biotech publishes unaudited first quarter results for 2024 (EQS Group)
26.03.24	Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. (EQS Group)
16.02.24	Sartorius Stedim Biotech releases Universal Registration Document 2023 (EQS Group)
07.02.24	Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders’ Meeting (EQS Group)
07.02.24	Sartorius Stedim Biotech SA: Sartorius Stedim Biotech S.A. successfully completes a EUR 1.2 billion share capital increase without shareholders’ preferential subscription rights (EQS Group)
26.01.24	Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook (EQS Group)
19.10.23	Sartorius Stedim Biotech SA: Nine-month results 2023 of Sartorius Stedim Biotech (EQS Group)
12.10.23	Sartorius Stedim Biotech SA: Sartorius Stedim Biotech pre-announces preliminary 9-month results and lowers forecast for 2023 (EQS Group)
21.07.23	Sartorius Stedim Biotech SA: Half-year results 2023 of Sartorius Stedim Biotech (EQS Group)
18.07.23	Sartorius Stedim Biotech SA: Sartorius Stedim Biotech completes acquisition of Polyplus (EQS Group)
16.06.23	Sartorius Stedim Biotech lowers forecast for 2023 (EQS Group)
20.04.23	Sartorius Stedim Biotech SA: First-quarter results 2023 of Sartorius Stedim Biotech (EQS Group)
31.03.23	Sartorius Stedim Biotech SA: Sartorius Stedim Biotech to acquire Polyplus (EQS Group)
27.03.23	Sartorius Stedim Biotech SA: René Fáber takes over as Chief Executive Officer of Sartorius Stedim Biotech S.A.; Joachim Kreuzburg remains Chairman of the Board (EQS Group)
08.02.23	Sartorius Stedim Biotech SA: Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 1.44 euros per share to the Annual Shareholders Meeting (EQS Group)
03.04.17	Sartorius Stedim Biotech (SSB) Acquires Leading Biopharma Software Developer Umetrics (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Roche Hldg G	265.50	2.04 %	K V
Lonza Grp	569.20	1.43 %	K V
Novartis	94.03	1.40 %	K V
Geberit	613.00	0.79 %	K V
Part Grp Hldg	1’102.00	0.78 %	K V
CieFinRichemont	154.85	-0.67 %	K V
Kuehne+Nagel Int	185.05	-0.80 %	K V
ABB	46.54	-1.61 %	K V
Logitech Intl	68.44	-2.34 %	K V
Holcim	91.02	-2.57 %	K V

Sartorius Stedim Biotech Aktie VALOR 32518471 / ISIN FR0013154002

Nachrichten zu Sartorius Stedim Biotech

Aktien Top/Flop

Sartorius Stedim Biotech Peer Group Nachrichten

Meistgelesene Nachrichten